1 |
Shamshiev, A., Gober, H. J., Donda, A., Mazorra, Z., Mori, L. and De Libero, G. (2002) Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195, 1013-1021.
DOI
|
2 |
Porubsky, S., Speak, A. O., Luckow, B., Cerundolo, V., Platt, F. M. and Grone, H. J. (2007) Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. U. S. A. 104, 5977-5982.
DOI
ScienceOn
|
3 |
Gumperz, J. E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., Koezuka, Y., Porcelli, S. A., Cardell, S., Brenner, M. B. and Behar, S. M. (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221.
DOI
ScienceOn
|
4 |
Jahng, A., Maricic, I., Aguilera, C., Cardell, S., Halder, R. C. and Kumar, V. (2004) Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199, 947-957.
DOI
ScienceOn
|
5 |
Arrenberg, P., Halder, R., Dai, Y., Maricic, I. and Kumar, V. (2010) Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta- linked self-glycolipid. Proc. Natl. Acad. Sci. U. S. A. 107, 10984-10989.
DOI
ScienceOn
|
6 |
Kang, S. J. and Cresswell, P. (2002) Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 277, 44838-44844.
DOI
ScienceOn
|
7 |
Hughes, E. A. and Cresswell, P. (1998) The thiol oxidoreductase ERp57 is a component of the MHC class I peptide- loading complex. Current biology : CB 8, 709-712.
DOI
|
8 |
Morrice, N. A. and Powis, S. J. (1998) A role for the thiol- dependent reductase ERp57 in the assembly of MHC class I molecules. Current biology: CB 8, 713-716.
DOI
|
9 |
Dougan, S. K., Salas, A., Rava, P., Agyemang, A., Kaser, A., Morrison, J., Khurana, A., Kronenberg, M., Johnson, C., Exley, M., Hussain, M. M. and Blumberg, R. S. (2005) Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 202, 529-539.
DOI
ScienceOn
|
10 |
Lawton, A. P., Prigozy, T. I., Brossay, L., Pei, B., Khurana, A., Martin, D., Zhu, T., Spate, K., Ozga, M., Honing, S., Bakke, O. and Kronenberg, M. (2005) The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms. J. Immunol. 174, 3179-3186.
DOI
|
11 |
Cernadas, M., Sugita, M., van der Wel, N., Cao, X., Gumperz, J. E., Maltsev, S., Besra, G. S., Behar, S. M., Peters, P. J. and Brenner, M. B. (2003) Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. J. Immunol. 171, 4149-4155.
DOI
|
12 |
Elewaut, D., Lawton, A. P., Nagarajan, N. A., Maverakis, E., Khurana, A., Honing, S., Benedict, C. A., Sercarz, E., Bakke, O., Kronenberg, M. and Prigozy, T. I. (2003) The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells. J. Exp. Med. 198, 1133-1146.
DOI
ScienceOn
|
13 |
Prigozy, T. I., Naidenko, O., Qasba, P., Elewaut, D., Brossay, L., Khurana, A., Natori, T., Koezuka, Y., Kulkarni, A. and Kronenberg, M. (2001) Glycolipid antigen processing for presentation by CD1d molecules. Science 291, 664-667.
DOI
ScienceOn
|
14 |
Hiltbold, E. M. and Roche, P. A. (2002) Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Immunol. 14, 30-35.
DOI
ScienceOn
|
15 |
Salio, M., Ghadbane, H., Dushek, O., Shepherd, D., Cypen, J., Gileadi, U., Aichinger, M. C., Napolitani, G., Qi, X., van der Merwe, P. A., Wojno, J., Veerapen, N., Cox, L. R., Besra, G. S., Yuan, W., Cresswell, P. and Cerundolo, V. (2013) Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation. Proc. Natl. Acad. Sci. U. S. A. 110, E4753-4761.
DOI
ScienceOn
|
16 |
Kang, S. J. and Cresswell, P. (2004) Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 5, 175-181.
|
17 |
Zhou, D., Cantu, C., 3rd, Sagiv, Y., Schrantz, N., Kulkarni, A. B., Qi, X., Mahuran, D. J., Morales, C. R., Grabowski, G. A., Benlagha, K., Savage, P., Bendelac, A. and Teyton, L. (2004) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303, 523-527.
DOI
ScienceOn
|
18 |
Sugita, M., Cao, X., Watts, G. F., Rogers, R. A., Bonifacino, J. S. and Brenner, M. B. (2002) Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 16, 697-706.
DOI
ScienceOn
|
19 |
Jayawardena-Wolf, J., Benlagha, K., Chiu, Y. H., Mehr, R. and Bendelac, A. (2001) CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15, 897-908.
DOI
ScienceOn
|
20 |
Porcelli, S. A. (1995) The CD1 family: a third lineage of antigen-presenting molecules. Adv. Immunol. 59, 1-98.
DOI
|
21 |
Calabi, F., Jarvis, J. M., Martin, L. and Milstein, C. (1989) Two classes of CD1 genes. Eur. J. Immunol. 19, 285-292.
DOI
ScienceOn
|
22 |
de la Salle, H., Mariotti, S., Angenieux, C., Gilleron, M., Garcia-Alles, L. F., Malm, D., Berg, T., Paoletti, S., Maitre, B., Mourey, L., Salamero, J., Cazenave, J. P., Hanau, D., Mori, L., Puzo, G. and De Libero, G. (2005) Assistance of microbial glycolipid antigen processing by CD1e. Science 310, 1321-1324.
DOI
ScienceOn
|
23 |
Moody, D. B., Young, D. C., Cheng, T. Y., Rosat, J. P., Roura-Mir, C., O'Connor, P. B., Zajonc, D. M., Walz, A., Miller, M. J., Levery, S. B., Wilson, I. A., Costello, C. E. and Brenner, M. B. (2004) T cell activation by lipopeptide antigens. Science 303, 527-531.
DOI
ScienceOn
|
24 |
Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T. and Brenner, M. B. (1994) Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372, 691-694.
DOI
ScienceOn
|
25 |
Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J. and Modlin, R. L. (1995) CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230.
DOI
|
26 |
Shamshiev, A., Donda, A., Prigozy, T. I., Mori, L., Chigorno, V., Benedict, C. A., Kappos, L., Sonnino, S., Kronenberg, M. and De Libero, G. (2000) The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 13, 255-264.
DOI
ScienceOn
|
27 |
Im, J. S., Arora, P., Bricard, G., Molano, A., Venkataswamy, M. M., Baine, I., Jerud, E. S., Goldberg, M. F., Baena, A., Yu, K. O., Ndonye, R. M., Howell, A. R., Yuan, W., Cresswell, P., Chang, Y. T., Illarionov, P. A., Besra, G. S. and Porcelli, S. A. (2009) Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 30, 888-898.
DOI
ScienceOn
|
28 |
Chiu, Y. H., Jayawardena, J., Weiss, A., Lee, D., Park, S. H., Dautry-Varsat, A. and Bendelac, A. (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189, 103-110.
DOI
|
29 |
Chiu, Y. H., Park, S. H., Benlagha, K., Forestier, C., Jayawardena-Wolf, J., Savage, P. B., Teyton, L. and Bendelac, A. (2002) Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 3, 55-60.
DOI
ScienceOn
|
30 |
Bai, L., Sagiv, Y., Liu, Y., Freigang, S., Yu, K. O., Teyton, L., Porcelli, S. A., Savage, P. B. and Bendelac, A. (2009) Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer. Proc. Natl. Acad. Sci. U. S. A. 106, 10254-10259.
DOI
ScienceOn
|
31 |
Shin, J. H., Park, J. Y., Shin, Y. H., Lee, H., Park, Y. K., Jung, S. and Park, S. H. (2012) Mutation of a positively charged cytoplasmic motif within CD1d results in multiple defects in antigen presentation to NKT cells. J. Immunol. 188, 2235-2243.
DOI
ScienceOn
|
32 |
Kang, S. J. and Cresswell, P. (2002) Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J. 21, 1650-1660.
DOI
ScienceOn
|
33 |
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629.
DOI
ScienceOn
|
34 |
Moody, D. B., Ulrichs, T., Muhlecker, W., Young, D. C., Gurcha, S. S., Grant, E., Rosat, J. P., Brenner, M. B., Costello, C. E., Besra, G. S. and Porcelli, S. A. (2000) CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404, 884-888.
DOI
ScienceOn
|
35 |
Matsunaga, I., Bhatt, A., Young, D. C., Cheng, T. Y., Eyles, S. J., Besra, G. S., Briken, V., Porcelli, S. A., Costello, C. E., Jacobs, W. R., Jr. and Moody, D. B. (2004) Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J. Exp. Med. 200, 1559-1569.
DOI
ScienceOn
|
36 |
Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M. and Chapman, P. B. (2003) Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181.
DOI
ScienceOn
|
37 |
Bendelac, A., Savage, P. B. and Teyton, L. (2007) The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336.
DOI
ScienceOn
|
38 |
Borg, N. A., Wun, K. S., Kjer-Nielsen, L., Wilce, M. C., Pellicci, D. G., Koh, R., Besra, G. S., Bharadwaj, M., Godfrey, D. I., McCluskey, J. and Rossjohn, J. (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448, 44-49.
DOI
ScienceOn
|
39 |
Geissmann, F., Cameron, T. O., Sidobre, S., Manlongat, N., Kronenberg, M., Briskin, M. J., Dustin, M. L. and Littman, D. R. (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3, e113.
DOI
ScienceOn
|
40 |
Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y. and Van Kaer, L. (2001) The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7, 1052-1056.
DOI
ScienceOn
|
41 |
Kim, H. Y., Kim, H. J., Min, H. S., Kim, S., Park, W. S., Park, S. H. and Chung, D. H. (2005) NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production. J. Exp. Med. 201, 41-47.
DOI
ScienceOn
|
42 |
Hong, C. and Park, S. H. (2007) Application of natural killer T cells in antitumor immunotherapy. Crit. Rev. Immunol. 27, 511-525.
DOI
|
43 |
Blomqvist, M., Rhost, S., Teneberg, S., Lofbom, L., Osterbye, T., Brigl, M., Mansson, J. E. and Cardell, S. L. (2009) Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur. J. Immunol. 39, 1726-1735.
DOI
ScienceOn
|
44 |
Thomas, S. Y., Scanlon, S. T., Griewank, K. G., Constantinides, M. G., Savage, A. K., Barr, K. A., Meng, F., Luster, A. D. and Bendelac, A. (2011) PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J. Exp. Med. 208, 1179-1188.
DOI
ScienceOn
|
45 |
Halder, R. C., Aguilera, C., Maricic, I. and Kumar, V. (2007) Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J. Clin. Invest. 117, 2302-2312.
DOI
ScienceOn
|
46 |
Ohteki, T., Maki, C., Koyasu, S., Mak, T. W. and Ohashi, P. S. (1999) Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways. J. Immunol. 162, 3753-3756.
|
47 |
Ambrosino, E., Terabe, M., Halder, R. C., Peng, J., Takaku, S., Miyake, S., Yamamura, T., Kumar, V. and Berzofsky, J. A. (2007) Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J. Immunol. 179, 5126-5136.
DOI
|
48 |
Lu, X., Song, L., Metelitsa, L. S. and Bittman, R. (2006) Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells. Chembiochem 7, 1750-1756.
DOI
ScienceOn
|
49 |
Wipf, P. and Pierce, J. G. (2006) Expedient synthesis of the alpha-C-glycoside analogue of the immunostimulant galactosylceramide (KRN7000). Org. Lett. 8, 3375-3378.
DOI
ScienceOn
|
50 |
Yang, G., Schmieg, J., Tsuji, M. and Franck, R. W. (2004) The C-glycoside analogue of the immunostimulant alpha- galactosylceramide (KRN7000): synthesis and striking enhancement of activity. Angew. Chem. Int. Ed. Engl. 43, 3818-3822.
DOI
ScienceOn
|
51 |
Schmieg, J., Yang, G., Franck, R. W. and Tsuji, M. (2003) Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J. Exp. Med. 198, 1631-1641.
DOI
ScienceOn
|
52 |
Oki, S., Tomi, C., Yamamura, T. and Miyake, S. (2005) Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int. Immunol. 17, 1619-1629.
DOI
ScienceOn
|
53 |
Kinjo, Y., Tupin, E., Wu, D., Fujio, M., Garcia-Navarro, R., Benhnia, M. R., Zajonc, D. M., Ben-Menachem, G., Ainge, G. D., Painter, G. F., Khurana, A., Hoebe, K., Behar, S. M., Beutler, B., Wilson, I. A., Tsuji, M., Sellati, T. J., Wong, C. H. and Kronenberg, M. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7, 978-986.
DOI
ScienceOn
|
54 |
Kinjo, Y., Wu, D., Kim, G., Xing, G. W., Poles, M. A., Ho, D. D., Tsuji, M., Kawahara, K., Wong, C. H. and Kronenberg, M. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525.
DOI
ScienceOn
|
55 |
Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C., 3rd, Zhou, D., Saint-Mezard, P., Wang, V., Gao, Y., Yin, N., Hoebe, K., Schneewind, O., Walker, D., Beutler, B., Teyton, L., Savage, P. B. and Bendelac, A. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529.
DOI
ScienceOn
|
56 |
Exley, M., Garcia, J., Balk, S. P. and Porcelli, S. (1997) Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J. Exp. Med. 186, 109-120.
DOI
|
57 |
Amprey, J. L., Im, J. S., Turco, S. J., Murray, H. W., Illarionov, P. A., Besra, G. S., Porcelli, S. A. and Spath, G. F. (2004) A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895-904.
DOI
ScienceOn
|
58 |
Bendelac, A. (1995) Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182, 2091-2096.
DOI
ScienceOn
|
59 |
Bendelac, A. (1995) CD1: presenting unusual antigens to unusual T lymphocytes. Science 269, 185-186.
DOI
|
60 |
Bendelac, A., Killeen, N., Littman, D. R. and Schwartz, R. H. (1994) A subset of CD4+ thymocytes selected by MHC class I molecules. Science 263, 1774-1778.
DOI
|
61 |
Zhang, G., Nie, H., Yang, J., Ding, X., Huang, Y., Yu, H., Li, R., Yuan, Z. and Hu, S. (2011) Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 301, L975-984.
DOI
|
62 |
Yu, K. O., Im, J. S., Molano, A., Dutronc, Y., Illarionov, P. A., Forestier, C., Fujiwara, N., Arias, I., Miyake, S., Yamamura, T., Chang, Y. T., Besra, G. S. and Porcelli, S. A. (2005) Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl. Acad. Sci. U. S. A. 102, 3383-3388.
DOI
ScienceOn
|
63 |
Zhou, D., Mattner, J., Cantu, C., 3rd, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y. P., Yamashita, T., Teneberg, S., Wang, D., Proia, R. L., Levery, S. B., Savage, P. B., Teyton, L. and Bendelac, A. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789.
DOI
ScienceOn
|
64 |
Facciotti, F., Ramanjaneyulu, G. S., Lepore, M., Sansano, S., Cavallari, M., Kistowska, M., Forss-Petter, S., Ni, G., Colone, A., Singhal, A., Berger, J., Xia, C., Mori, L. and De Libero, G. (2012) Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat. Immunol. 13, 474-480.
DOI
ScienceOn
|
65 |
Brozovic, S., Nagaishi, T., Yoshida, M., Betz, S., Salas, A., Chen, D., Kaser, A., Glickman, J., Kuo, T., Little, A., Morrison, J., Corazza, N., Kim, J. Y., Colgan, S. P., Young, S. G., Exley, M. and Blumberg, R. S. (2004) CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 10, 535-539.
DOI
ScienceOn
|
66 |
Jung, S., Shin, H. S., Hong, C., Lee, H., Park, Y. K., Shin, J. H., Hong, S., Lee, G. R. and Park, S. H. (2009) Natural killer T cells promote collagen-induced arthritis in DBA/1 mice. Biochem. Biophys. Res. Commun. 390, 399-403.
DOI
ScienceOn
|
67 |
Barral, D. C. and Brenner, M. B. (2007) CD1 antigen presentation: how it works. Nat. Rev. Immunol. 7, 929-941.
DOI
ScienceOn
|
68 |
Brigl, M. and Brenner, M. B. (2004) CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890.
DOI
ScienceOn
|
69 |
Rock, K. L., York, I. A., Saric, T. and Goldberg, A. L. (2002) Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 80, 1-70.
DOI
|
70 |
Zeng, Z., Castano, A. R., Segelke, B. W., Stura, E. A., Peterson, P. A. and Wilson, I. A. (1997) Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345.
DOI
ScienceOn
|
71 |
Yuan, W., Qi, X., Tsang, P., Kang, S. J., Illarionov, P. A., Besra, G. S., Gumperz, J. and Cresswell, P. (2007) Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc. Natl. Acad. Sci. U. S. A. 104, 5551-5556.
DOI
ScienceOn
|